3-(Bromomethyl)-1-methyl-1H-pyrazole → HCID 57422457, 화합물
반응식
[CH3:1][C:2]1[C:6]([CH2:7][N:8]2[CH:12]=[C:11]([N:13]3[C:17](=[O:18])[CH2:16][NH:15][C:14]3=[O:19])[CH:10]=[N:9]2)=[C:5]([CH3:20])[O:4][N:3]=1.Br[CH2:22][C:23]1[CH:27]=[CH:26][N:25]([CH3:28])[N:24]=1>>[CH3:1][C:2]1[C:6]([CH2:7][N:8]2[CH:12]=[C:11]([N:13]3[C:17](=[O:18])[CH2:16][N:15]([CH2:22][C:23]4[CH:27]=[CH:26][N:25]([CH3:28])[N:24]=4)[C:14]3=[O:19])[CH:10]=[N:9]2)=[C:5]([CH3:20])[O:4][N:3]=1참가 물질
3
실험 절차
Prepared as in example 10-5 from 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)imidazolidine-2,4-dione (example 10-1) and 3-(bromomethyl)-1-methyl-1H-pyrazole. Yield 19%. MS M+H calculated 370.1. Found 370. The title compound was shown to inhibit hT2R08 bitter receptor and had an IC50 of 0.4 uM.
출처 및 근거
- ORD 기록
- ord-ed9b00b285ae475ebd37bf2ae85172da
- 출처 데이터셋
- uspto-grants-2016_02
- 특허 번호
- US09247759B2
반응 노트
불러오는 중…